I'm going to have to disagree with you there mate. Good Aus pedi...

I'm going to have to disagree with you there mate.

Good Aus pedi results = TGA + CE approvals

It might also mean CFDA approvals!!

"China is planning to accept data generated from clinical trials run overseas. The proposal is part of a suite of changes put forward by the State Council to boost China’s support for innovative drugs and devices and accelerate their path to patients."

See this link:
https://www.raps.org/news-articles/...ial-data-for-accelerated-approvals-(10-octobe

This would be MASSIVE. The telehealth numbers in China are staggering.

In 2017 PingAn had 370,000 telehealth consults per day and was growing at +100% per year (this is not a typo).

We are told that 30-50% of all consults are for respiratory disease. That's around 100k - 200k consults for respiratory disease per day and at $5/test this is USD 500k - 1m revenue per day! The numbers are staggering.

There will be no other product on the market like ResAppDx.

Good Australian results will see a huge re-rate IMO.

Good luck to all in the coming days.

D.